EquityFlow › Investors › Cancer Research Horizons

Cancer Research Horizons Investor

At a glance

1 portfolio companies
1 rounds
0 led
$92.8M total

Portfolio

CompanyRoundsInvested
Trogenix
Biotech
1 round$92.8M

Frequently co-invests with

Meltwind 1Brain Tumor Investment Fund 14BIO Capital 1LongeVC 1IQ Capital 1Calculus Capital 1Eli Lilly 1
Explore investors on EquityFlow →